FDA
-
-
-
-
-
-
-
FDA Approves Hepcludex injection to treat chronic Hepatitis Delta virus infection in adults w/o Cirrhosis or w/ compensated Cirrhosis
-
-
-
-
-
-
-
FDA grants priority review to Gilead's HIV treatment combination
-
-
-
-
-
-
-
Goldman Sachs: 'we expect GILD to continue to engage in strategic BD'
-
-
-
-
-
-
-
Morgan Stanley: 'Big picture this acquisition bolsters GILD's established position in CAR-T in oncology'
-
-
-
-
-
-
-
FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
-
-
-
-
-
-
-
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
-
-
-
-
-
-
-
Gilead HIV drug combination meets trial endpoint for complex regimens
-
322,094 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

